|会社名||Cronos Group Inc （クロノス・グル―プ）|
|分野（sector）||Consumer Durables 耐久消費財|
|業種||― 医療関連（Health Care）|
|概要||事業概要 -- クロノス・グル―プはカナダの医療用大麻事業会社。医療目的大麻規制(MMPR)に基づき、カナダ保健省が発行した医療用大麻生産ライセンスを所有または申請する企業への投資を中心に事業を行う。また、子会社を通じ、大麻油の栽培や医療用大麻の生産および販売にも従事する。本社所在地はトロント。|
|本社所在地||720 King Street West Suite 320 Toronto Ontario M5V 2T3 CAN|
|市場名||NASDAQ National Market System|
Cronos Group Inc. to Hold 2020 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2021 | MarketScreener 2021/02/12 14:00:08 MarketScreener
TORONTO, Feb. 12, 2021 -- Cronos Group Inc. will hold its 2020 Fourth Quarter and Full-year Earnings Conference Call on Friday, February 26, 2021 at 8:30 a.m. EST. Cronos Group’s… | February 12, 2021
Cronos Group Inc. to Hold 2020 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2021 2021/02/12 14:00:00 GlobeNewswire
TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2020 Fourth…
Cronos Group Inc. stock outperforms competitors despite losses on the day 2021/02/11 22:04:00 MarketWatch
Shares of Cronos Group Inc. plummeted 21.86% to $12.15 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the…
Cannabis Stock Squeeze: Option Traders Eyeing New Highs For Tilray (TLRY) 2021/02/10 20:59:41 Benzinga
With cannabis stocks in the news this week, we’ll reveal what the options market is expecting in terms of upcoming stock moves and look at how options can play a role in potential short-squeeze situations. Using Tilray, Inc. (NASDAQ: TLRY ) as an example, we’ll also look at how spreads might be used in a high-premium environment to reduce capital outlay – whatever your trading view. Overview and Expected Moves First, a comparison of some of the expected moves over the next month for Tilray, Canopy Growth Corporation (NASDAQ: CGC ), Aurora Cannabis Inc. (NYSE: ACB ), Aphria Inc. (NASDAQ: APHA ) and Cronos Group Inc. (NASDAQ: CRON ) via the Options AI Calculator With Tilray (TLRY) trading about $55, the options market is pricing an expected move for the month of over 60% in either direction. (note – the company is set to report earnings the first week of March). The move being priced in options corresponds to about $90 for a bullish consensus and $20 bearish: Short Squeezes and Option Strikes At the time of writing, the highest near-dated option strike is 65.
Cronos Group Is Showing Us a Bullish Picture 2021/02/09 20:00:00 The Street RealMoney
Traders should look to buy available weakness into the $12-$11 area….CRON
$CRON #CRONOSINC - Mixed Equities As Feds Stands Still 2020/12/17 14:30:09 CentralCharts
STATE OF THE MARKETS Mixed equities as Feds stands still. US equities finished mixed Wednesday, with Dow fell 45 points (-0.2%), S&P500 edged 7 points higher (+0.2%) and Nasdaq climbed 63 points (+0.5%) when the Federal Reserve kept its rate unchanged and vowed to support the economy until full employment is restored. Treasury yields moved higher on the news, with the 10Y benchmark reached as high as 0.96% before settled at 0.92%. Crude continued its upward trajectory, to close above $47.80, running through all stops around $48.00/20 when EIA reported that US crude inventories was reduced by 3.1m barrels last Friday. Similarly, gold advanced higher, closing above $1864.10, as inflation become primary concern for 2021. In the FX space, Dollar seemed supported by CAD in the short and medium term, albeit temporarily on year end profit taking. Yen retained lead in demand against the commodity CAD in all three horizons as CBOE put/call ratio increased, which signaled more safe-haven demand as evident in more inflows to bond than stocks.
The men who engineered the biggest merger in cannabis lay out why the $4 billion tie-up makes the new Tilray an enticing target for a strategic partner 2020/12/16 21:45:40 Business Insider
Summary List Placement Canadian cannabis producers Tilray and Aphria are merging in a blockbuster deal that would give the combined firm a near $4 billion valuation and make it the world's largest cannabis company by revenue, the companies announced on Wednesday morning. Aphria CEO Irwin Simon and Tilray CEO Brendan Kennedy said in a Wednesday morning interview with Business Insider that the merger would be a boon to shareholders of both companies and that it would give the combined company an effective platform to take advantage of the potentially $100 billion US cannabis market . Aphria agreed in November to acquire the US brewer SweetWater Brewing Company and Tilray owns a US CBD business, Manitoba Harvest. On top of that, it would also make the combined company an attractive target for a large strategic partner, like beer giant Constellation Brands' investment into cannabis rival Canopy Growth, or Altria's investment into Cronos Group. Sending a message to potential partners "A number of large strategic investors in the US, and a number of large strategic investors globally have been waiting to identify who are going to be the consolidators or what companies are going to consolidate the industry," Kennedy told BI. "I think Irwin and I sent a message today with this combination," Kennedy said.
Cannabis Stocks Watchlist: Canopy Growth Falls After Closures 2020/12/13 16:00:00 The Street
See how cannabis stocks such as GW Pharmaceuticals, Canopy Growth and Cronos Group performed in the market this week.
Cannabis Stocks Spotlight: Canopy Growth vs. Cronos Group 2020/12/08 12:55:07 Schaeffers Investment Research
A comparison of the technicals and fundamentals behind CGC and CRON
Cannabis Industry Launches Unique Vape Recycling Program, Partners with Leading Recycler 2020/12/01 14:00:00 Cision (Canada)
/CNW/ - Leading Canadian cannabis companies – 48North, Aurora Cannabis, Aphria Inc., Canopy Growth, Cronos Group – and the Cannabis Council of Canada ('C3'),…
Why Cannabis Stocks Are Trading Lower Today 2020/09/23 12:21:00 Benzinga
Shares of several cannabis companies such as Canopy Growth Corporation (NYSE: CGC), Tilray, Inc. (NASDAQ: TLRY) and Cronos Group Inc. (NASDAQ: CRON) are …
Cronos Group replaces CEO with consumer packaged goods veteran 2020/09/09 15:02:55 Marijuana Business Daily
Cronos Group has become the latest Canadian cannabis company to shake up its top ranks, replacing former CEO Mike Gorenstein with experienced consumer packaged goods executive Kurt Schmidt. The announcement comes just one day after major Canadian producer Aurora Cannabis announced its new CEO. Schmidt’s appointment was the result of a year-long search for “an […] Cronos Group replaces CEO with consumer packaged goods veteran is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Why Cannabis Is An Afterthought In The Biden-Trump Election 2020/08/25 19:25:56 Benzinga
The S&P 500 has rallied hard off the index's March lows and is back at new all-time highs. Unfortunately for cannabis investors, cannabis stocks like Canopy Growth Corp (NYSE: CGC ), Cronos Group Inc (NASDAQ: CRON ) and Aurora Cannabis Inc (NYSE: ACB ) are still down sharply in 2020. No Pre-Election Highs For Cannabis Stocks: One of the most disappointing observations for cannabis stock investors is how poorly the stocks are performing with a little more than two months remaining until the U.S. presidential election. Cannabis legalization appears to be an afterthought at this point for both Democratic nominee Joe Biden and incumbent Republican President Donald Trump, DataTrek Research co-founder Jessica Rabe said Tuesday. Expecting Trump and the Republican Party to change their tune on cannabis may have been … Full story available on Benzinga.com
Top Wall Street analysts say these are the 7 cannabis stocks to bet on now that will benefit if Biden defeats Trump in November 2020/08/14 19:27:00 Business Insider
Wall Street analysts say a Democratic sweep in November that puts Joe Biden in the White House and the party in control of the Senate could be a boon for cannabis stocks. Analysts at CIBC and Cowen picked 7 stocks to bet on that would benefit if the Democrats win, including Green Thumb Industries, Curaleaf, and Canopy Growth. Visit Business Insider's homepage for more stories . As public support for cannabis reform picks up steam in the US, Wall Street analysts say signs are pointing to a turnaround in the formerly troubled sector, especially as a few companies posted solid earnings over the past week. Vivien Azer, a cannabis-industry analyst at the investment bank Cowen, said in an August 7 note that Democratic nominee Joe Biden's polling lead is a "positive sign for the industry." That, on top of the coronavirus-pandemic-induced sales bump , has upped investor confidence in the sector after months of stock declines and layoffs. While Azer says that real power on cannabis reform rests in the Senate, rather than the White House, "we reiterate the view that a Democratic sweep means 2021 legalization." Read more : The CEO of Canopy Growth lays out 3 reasons he's 'never been more bullish' on the cannabis industry John Zamparo, a cannabis-industry analyst at CIBC, said in a July 17 note that a Democratic victory in November could boost US firms as well as Canadian cannabis firms with interests in expanding to the US. "A clean sweep by the Democrats would, in our opinion, most benefit Canadian operators with strong balance sheets and US ambitions," Zamparo said.
関連キーワード （― 米国株 クロノス・グル―プ CRON Cronos Group Inc.）